Eastman Chemical (EAC) AI Stock Analysis

Eastman Chemical

(XETRA:EAC)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Circular Materials ExpansionRestored DOE support lowers Eastman’s required capital for circular expansion while enabling additional methanolysis and feed-processing capacity. This improves project economics, strengthens the company’s recycled-materials offering, and supports a more durable sustainability-led growth platform.

Negative Factors

Margin CompressionProfitability remains materially below 2024 levels despite improved net income versus 2025. Persistent margin compression reduces internal funding capacity, limits deleveraging, and leaves earnings more exposed to unfavorable product mix, pricing, or input-cost movements.

Eastman Chemical (EAC) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 7.61B
Dividend Yield: 4.94%
Average Volume (3M): 43
Price to Earnings (P/E): 11.7
Beta (1Y): 0.86
Revenue Growth: -4.66%
EPS Growth: -12.80%
Country: Germany
Employees: 13,000
Sector: Basic Materials
Sector Strength: 61
Industry: Chemicals - Specialty

Eastman Chemical Business Overview & Revenue Model

Company Description

Eastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived bu...

Eastman Chemical Earnings Call Summary

Earnings Call Date:Oct 28, 2026(Q3-2026)|% Change Since:-1.66%|Next Earnings Date:Feb 03, 2027

Earnings Call SentimentPositive

The call was broadly positive. Management highlighted the reinstated DOE grant, lower-capital circular expansion, strong innovation-driven volume growth, record earnings expectations for AFP and functional amines, the high-return metathesis project, and expected 2027 volume and cash-flow improvement. These positives outweighed challenges including macroeconomic weakness, automotive and construction declines, Q4 price-cost and Chemical Intermediates pressure, project delays, elevated working capital, and acetate tow pricing declines.

Positive Updates

DOE Grant Reinstated at Full Value

Eastman regained the Department of Energy grant at its full value. The DOE can fund up to 50% of eligible capital, and management expects the grant to cover approximately 30% to 50% of the combined investment for the Kingsport expansion and second methanolysis plant.

Negative Updates

Advanced Materials Price-Cost Headwind

Advanced Materials faces an approximately $30 million full-year price-cost headwind, with about half occurring in Q4 in Specialty Plastics. Higher PX prices created an approximately $15 million headwind relative to prior expectations, versus an earlier expectation of a greater than $15 million tailwind.

Company Guidance

Guidance included Advanced Materials volume mix of about 3% up for the full year, circular revenue up to $100 million in 2026 and $100 million as a minimum for 2027, with incremental circular earnings around $20 million this year and expected to be at or above those in 2027; operating cash flow around $850 million for 2026, with significant cash flow above the $850 million in 2027; 2026 CapEx of $400 million and a 2027 baseline starting point around $500 million; DOE coverage of 30% to 50% of the capital cost for the combined investment and roughly 50% of additional investments in '28 and the future; metathesis earnings of $75 million to $125 million, about $100 million on average, with a payback in 1 to 2 years and the project online in the middle of 2028; another mid-single-digit decline in acetate tow prices in 2027 with improvement in volume and earnings stable to this year; and volume growth in AM, AFP, and Fibers next year relative to this year, with volumes similar to this year in CI.

Eastman Chemical Risk Analysis

Eastman Chemical disclosed 16 risk factors in its most recent earnings report. Eastman Chemical reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Eastman Chemical Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

DE:EAC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CBT	66Neutral	$3.84B	20.62	12.07%	2.48%	-4.74%	-53.83%
LYB	65Neutral	$22.17B	41.60	12.54%	5.01%	-1.83%	―
Sector *	61Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
AVNT	58Neutral	$3.93B	23.03	7.17%	2.57%	2.36%	42.56%
ASH	56Neutral	$3.42B	65.51	2.77%	2.24%	-1.39%	―
WLK	49Neutral	$8.73B	-7.10	-13.93%	3.11%	-3.95%	-1725.20%

* Basic Materials Sector Average

Performance Comparison

DE:EAC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:EAC	Eastman Chemical Company	59.26	11.48	24.03%
ASH	Ashland Global Holdings, Inc.	74.68	27.76	59.17%
CBT	Cabot Corp	74.43	10.10	15.69%
LYB	Lyondellbasell Industries	68.64	25.11	57.70%
AVNT	Avient Corporation	42.84	11.74	37.74%
WLK	Westlake Corporation	68.28	1.80	2.71%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Eastman Chemical AI Stock Analysis